FTC sues big pharmacy gain supervisors above insulin selling prices The company introduced motion towards Caremark, Express Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating techniques “artificially inflated” the record cost of everyday living-saving insulin drugs. The deal should be completed by Sept. 30 or consumers can terminate https://titusopopo.suomiblog.com/top-latest-five-healthcare-news-urban-news-46326440